Department of Biomedical Sciences, Chung Shan Medical University, Taichung, Taiwan, ROC.
Hum Genet. 2010 Sep;128(3):303-13. doi: 10.1007/s00439-010-0856-x. Epub 2010 Jul 1.
The crucial role of gap junctions, which are composed of connexin (CX) protein, in auditory functions has been confirmed by numerous studies. In this study, we investigate the prevalence and phenotype/genotype correlation of connexin (CX) gene family variants in a cohort of children with nonsyndromic hearing loss (HL). A total of 253 unrelated children with nonsyndromic HL were screened for the presence of variants in 6 genes of the CX gene family. The prevalence of CX gene variants in 253 patients was 19.7% (50/253). We found the frequency of a sloping audiometric configuration was significantly higher for children with GJB2 and GJB3 variants than for those with GJB4 and GJC3 variants (Adjusted OR = 4.89, p < 0.001). Conversely, the frequency of a flat audiometric configuration was significantly higher for children with GJB4 and GJC3 variants than for those with GJB2 and GJB3 variants (adjusted OR = 7.76, p < 0.001). The relative frequencies of multiplex families was significantly higher for children with GJB3 variants than for those with GJB2, GJB4, and GJC3 variants (Adjusted OR = 11.33, p = 0.003). Our results suggest the variants of GJC3, GJB4, and GJB3 may be the common genetic risk factor, after variants of GJB2, for the development of nonsyndromic HL in Taiwan. These data can be effectively applied to direct the clinical evaluation of children with CX gene variants.
缝隙连接由连接蛋白(connexin,CX)组成,其在听觉功能中的关键作用已被大量研究证实。本研究旨在探讨非综合征型听力损失(hearing loss,HL)患儿 CX 基因家族变异的流行情况及其与表型/基因型的相关性。我们对 253 例非综合征型 HL 患儿进行了 6 个 CX 基因家族基因变异的筛查。253 例患者中 CX 基因变异的患病率为 19.7%(50/253)。我们发现 GJB2 和 GJB3 变异患儿的听力图构型呈倾斜型的频率显著高于 GJB4 和 GJC3 变异患儿(校正优势比[OR] = 4.89,p < 0.001)。相反,GJB4 和 GJC3 变异患儿的听力图构型呈平坦型的频率显著高于 GJB2 和 GJB3 变异患儿(校正 OR = 7.76,p < 0.001)。GJB3 变异患儿的多重家系相对频率显著高于 GJB2、GJB4 和 GJC3 变异患儿(校正 OR = 11.33,p = 0.003)。上述结果提示 GJC3、GJB4 和 GJB3 基因的变异可能是非综合征型 HL 除 GJB2 变异以外的常见遗传危险因素。这些数据可有效应用于指导携带 CX 基因变异患儿的临床评估。